Acute Myeloid Leukemia With Recurrent Genetic Abnormalities Other Than Translocations.
No Mutation Left Behind: The Impact of Reporting Recurrent Genetic Abnormalities on Outcomes of Patients with Acute Myeloid Leukemia.
NPM1 mutations and cytoplasmic nucleophosmin are mutually exclusive of recurrent genetic abnormalities: a comparative analysis of 2562 patients with acute myeloid leukemia.
Acute Myeloid Leukemia: A Review.
Pelcovits A, Niroula R.
R I Med J (2013). 2020 Apr 1;103(3):38-40.
Acute myeloid leukaemia.
Short NJ, Rytting ME, Cortes JE.
Lancet. 2018 Aug 18;392(10147):593-606. doi: 10.1016/S0140-6736(18)31041-9. Epub 2018 Aug 2.
Acute myeloid leukaemia.
Khwaja A, Bjorkholm M, Gale RE, Levine RL, Jordan CT, Ehninger G, Bloomfield CD, Estey E, Burnett A, Cornelissen JJ, Scheinberg DA, Bouscary D, Linch DC.
Nat Rev Dis Primers. 2016 Mar 10;2:16010. doi: 10.1038/nrdp.2016.10.
A longitudinal single-cell atlas of treatment response in pediatric AML.
Lambo S, Trinh DL, Ries RE, Jin D, Setiadi A, Ng M, Leblanc VG, Loken MR, Brodersen LE, Dai F, Pardo LM, Ma X, Vercauteren SM, Meshinchi S, Marra MA.
Cancer Cell. 2023 Dec 11;41(12):2117-2135.e12. doi: 10.1016/j.ccell.2023.10.008. Epub 2023 Nov 16.
Minimal Residual Disease in Acute Myeloid Leukemia: Old and New Concepts.
Chea M, Rigolot L, Canali A, Vergez F.
Int J Mol Sci. 2024 Feb 10;25(4):2150. doi: 10.3390/ijms25042150.
Cytogenetics and genomics of acute myeloid leukemia.
Snaith O, Poveda-Rogers C, Laczko D, Yang G, Morrissette JJD.
Best Pract Res Clin Haematol. 2024 Mar;37(1):101533. doi: 10.1016/j.beha.2023.101533. Epub 2023 Dec 10.
Integrated Genomic Analysis Identifies UBTF Tandem Duplications as a Recurrent Lesion in Pediatric Acute Myeloid Leukemia.
Umeda M, Ma J, Huang BJ, Hagiwara K, Westover T, Abdelhamed S, Barajas JM, Thomas ME, Walsh MP, Song G, Tian L, Liu Y, Chen X, Kolekar P, Tran Q, Foy SG, Maciaszek JL, Kleist AB, Leonti AR, Ju B, Easton J, Wu H, Valentine V, Valentine MB, Liu YC, Ries RE, Smith JL, Parganas E, Iacobucci I, Hiltenbrand R, Miller J, Myers JR, Rampersaud E, Rahbarinia D, Rusch M, Wu G, Inaba H, Wang YC, Alonzo TA, Downing JR, Mullighan CG, Pounds S, Babu MM, Zhang J, Rubnitz JE, Meshinchi S, Ma X, Klco JM.
Blood Cancer Discov. 2022 May 5;3(3):194-207. doi: 10.1158/2643-3230.BCD-21-0160.
Maintenance therapy in acute myeloid leukemia: advances and controversies.
Senapati J, Kadia TM, Ravandi F.
Haematologica. 2023 Sep 1;108(9):2289-2304. doi: 10.3324/haematol.2022.281810.
Relapsed pediatric acute myeloid leukaemia: state-of-the-art in 2023.
Egan G, Tasian SK.
Haematologica. 2023 Sep 1;108(9):2275-2288. doi: 10.3324/haematol.2022.281106.
Acute myeloid leukemia: from NGS, through scRNA-seq, to CAR-T. dissect cancer heterogeneity and tailor the treatment.
Peroni E, Randi ML, Rosato A, Cagnin S.
J Exp Clin Cancer Res. 2023 Oct 6;42(1):259. doi: 10.1186/s13046-023-02841-8.
